Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020902636A
Inventor
David Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mucpharm Pty Ltd
Original Assignee
Mucpharm Pty Ltd
Filing date
Publication date
Application filed by Mucpharm Pty LtdfiledCriticalMucpharm Pty Ltd
Publication of AU2020902636A0publicationCriticalpatent/AU2020902636A0/en
Priority to US18/007,134priorityCriticalpatent/US20230226160A1/en
Priority to BR112023001508Aprioritypatent/BR112023001508A2/en
Priority to CN202180054181.4Aprioritypatent/CN116367852A/en
Priority to CA3187214Aprioritypatent/CA3187214A1/en
Priority to PCT/AU2021/050820prioritypatent/WO2022020892A1/en
Priority to AU2021317744Aprioritypatent/AU2021317744A1/en
Priority to EP21848920.1Aprioritypatent/EP4188424A1/en
COMPOSITION, METHODS FOR DEBRIDATING BIOFILM ON AN IMPLANT AND FOR TREATMENT OF A BACTERIAL INFECTION INVOLVING BIOFILM AND ON AN IMPLANT, AND, USE OF A COMBINATION OF A BIOFILM DEGRADATING PROTEASE, A DISULFIDE BONDING BREAKING AGENT AND AN ANTIBIOTICS